BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 20471843)

  • 1. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.
    Huang L; Luo Z; He F; Lu J; Li X
    Bioorg Med Chem; 2010 Jun; 18(12):4475-84. PubMed ID: 20471843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.
    Huang L; Shi A; He F; Li X
    Bioorg Med Chem; 2010 Feb; 18(3):1244-51. PubMed ID: 20056426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of berberine-thiophenyl hybrids as multi-functional agents: Inhibition of acetylcholinesterase, butyrylcholinesterase, and Aβ aggregation and antioxidant activity.
    Su T; Xie S; Wei H; Yan J; Huang L; Li X
    Bioorg Med Chem; 2013 Sep; 21(18):5830-40. PubMed ID: 23932451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation and molecular modeling of novel triazole-containing berberine derivatives as acetylcholinesterase and β-amyloid aggregation inhibitors.
    Shi A; Huang L; Lu C; He F; Li X
    Bioorg Med Chem; 2011 Apr; 19(7):2298-305. PubMed ID: 21397508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine derivatives, with substituted amino groups linked at the 9-position, as inhibitors of acetylcholinesterase/butyrylcholinesterase.
    Huang L; Luo Z; He F; Shi A; Qin F; Li X
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6649-52. PubMed ID: 20880702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
    Shan WJ; Huang L; Zhou Q; Meng FC; Li XS
    Eur J Med Chem; 2011 Dec; 46(12):5885-93. PubMed ID: 22019228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
    Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
    Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of novel 4-[(3H,3aH,6aH)-3-phenyl)-4,6-dioxo-2-phenyldihydro-2H-pyrrolo[3,4-d]isoxazol-5(3H,6H,6aH)-yl]benzoic acid derivatives as potent acetylcholinesterase inhibitors and anti-amnestic agents.
    Anand P; Singh B
    Bioorg Med Chem; 2012 Jan; 20(1):521-30. PubMed ID: 22172310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors.
    Shen Q; Peng Q; Shao J; Liu X; Huang Z; Pu X; Ma L; Li YM; Chan AS; Gu L
    Eur J Med Chem; 2005 Dec; 40(12):1307-15. PubMed ID: 16182411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.
    Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Kunimoto R; Tsumura Y; Akaike A; Niidome T; Okuno Y; Takahashi T; Sugimoto H
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1718-20. PubMed ID: 20137934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles.
    Samadi A; Marco-Contelles J; Soriano E; Alvarez-Pérez M; Chioua M; Romero A; González-Lafuente L; Gandía L; Roda JM; López MG; Villarroya M; García AG; Ríos Cde L
    Bioorg Med Chem; 2010 Aug; 18(16):5861-72. PubMed ID: 20656495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.
    Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Tsumura Y; Akaike A; Niidome T; Takahashi T; Sugimoto H
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1721-3. PubMed ID: 20137941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological activity, and docking studies of new acetylcholinesterase inhibitors of the bispyridinium type.
    Kapková P; Stiefl N; Sürig U; Engels B; Baumann K; Holzgrabe U
    Arch Pharm (Weinheim); 2003 Nov; 336(11):523-40. PubMed ID: 14639745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors.
    Wang C; Wu Z; Cai H; Xu S; Liu J; Jiang J; Yao H; Wu X; Xu J
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5212-6. PubMed ID: 26454504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterases.
    Alptüzün V; Prinz M; Hörr V; Scheiber J; Radacki K; Fallarero A; Vuorela P; Engels B; Braunschweig H; Erciyas E; Holzgrabe U
    Bioorg Med Chem; 2010 Mar; 18(5):2049-59. PubMed ID: 20149667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase.
    Alipour M; Khoobi M; Nadri H; Sakhteman A; Moradi A; Ghandi M; Foroumadi A; Shafiee A
    Arch Pharm (Weinheim); 2013 Aug; 346(8):577-87. PubMed ID: 23852709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Pan L; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3790-3. PubMed ID: 18524585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and acetylcholinesterase and butyrylcholinesterase inhibitory activities of 7-alkoxyl substituted indolizinoquinoline-5,12-dione derivatives.
    Wu ZP; Wu XW; Shen T; Li YP; Cheng X; Gu LQ; Huang ZS; An LK
    Arch Pharm (Weinheim); 2012 Mar; 345(3):175-84. PubMed ID: 21989769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
    Musilek K; Komloova M; Zavadova V; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K; Jung YS
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1763-6. PubMed ID: 20138518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Vafadarnejad F; Karimpour-Razkenari E; Sameem B; Saeedi M; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.